{"task_id": "37b7c2e16c9348ea", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 43/464)", "text": "ray 0.4 mg SL q5min \u00043.\n28\nAcute Coronary Syndrome\n\n--- Page 50 ---\nACUTE MANAGEMENT (CONT\u2019D)\nBeware if suspect right ventricular infarction or if\npatients on sildenafil). Morphine 2 4 mg IV every\n5 15 min PRN\nCLOT CONTROL\n\u0002\nANTIPLATELET\nASA 162 325 mg PO chew \u00041\ndose, then 75 162 mg PO daily (for medically\ntreated unstable angina/NSTEMI), or 162 325 mg\nPO daily (post PCI minimum \u00041 month for bare\nmetal stent, \u00043 months for sirolimus eluting stent,\nor \u00046 months for paclitaxel eluting stent), then\n75 162 mg PO daily indefinitely. If NSTEMI or\nSTEMI, clopidogrel 300 600 mg \u00041 dose then\n75 mg PO daily. Combination ASA plus clopidogrel\nfor minimum of 1 month (ideally 1 year) post PCI\nwith bare metal stent, or minimum 12 months\n(possibly indefinitely) for drug eluting stents. If\npost PCI, pain unresponsive to nitroglycerin or\nintermediate/high risk NSTEMI, consider GPIIb/\nIIIa inhibitor (tirofiban 0.4 mg/kg/min \u000430 min\nIV, then continue 0.1 mg/kg/min \u000418 24 h after\nangioplasty/atherectomy. Eptifibatide 180 mg/kg IV\nbolus, then 2 mg/kg/min \u000472 96 h)\n\u0002\nANTICOAGULATION\noptions include LMWH (enox\naparin 30 mg IV bolus, then 1 mg/kg SC BID for\nSTEMI [no IV bolus for NSTEMI caution if renal\nfailure or age >75) or unfractionated heparin\n(unfractionated heparin 70 U/kg [up to 4000U] IV\nbolus, then 18 U/kg/hr [up to 1000U/h] and adjust\nto 1.5 2.5\u0004 normal PTT for 72 h). Factor Xa\ninhibitors (Fondaparinux 2.5 mg SC daily until\nACUTE MANAGEMENT (CONT\u2019D)\ndischarge or 8 days, caution if renal failure). Direct\nthrombin inhibitors (Bivalirudin 0.1 mg/kg IV\nbolus then 0.25 mg/kg/hr initially, followed by\nsecond 0.5 mg/kg bolus before PCI and 1.75 mg/\nkg/hr during PCI, then continue infusion for up to\n4 h post PCI, if needed)\n\u0002\nREPERFUSION THERAPY\nsee PCI for details. Fibrino\nlytics (TPA 15 mg IV over 2 min, then 0.75 mg/kg\nover 30 min [maximum 50 mg], then 0.5 mg/kg over\n60 min [overall maximum 100 mg]. Streptokinase 1.5\nmillion units IV over 30 60 min. Tenectepalse IV\nbolus over 10 15 s, weight based: 30 mg for weight\n<60 kg, 35 mg for 60 69 kg, 40 mg for 70 79 kg,\n45 mg for 80 89 kg, 50 mg for \u000590 kg)\nRATE CONTROL\nIV metoprolol is mostly contra\nindicated. Start with metoprolol 25 mg PO BID and\ntitrate slowly. Alternatively, atenolol 25 mg PO daily\nand titrate to 100 mg PO daily. The goal heart rate is\n50 55 with normal activity. If b blocker contraindi\ncated, consider non dihydropyridine calcium chan\nnel blockers diltiazem 30 120 mg PO QID or verapa\nmil 80 120 mg PO TID (contraindicated if LV\ndysfunction)\nLIPID CONTROL\nsimvastatin 40 mg PO daily or\natorvastatin 80 mg PO daily\nBLOOD PRESSURE SUPPORT\nfor patients with\ncardiogenic shock, consider IV fluids, inotropes\n(dobutamine/dopamine), balloon pump, and early\nrevascularization\nOVERALL APPROACH\nStable angina\nUnstable angina or NSTEMI\nSTEMI\nASA\nX\nX\nX\nNitrates\nX\nX\nX\nMorphine\n\u0007\nX\nX\nb blockers\nX\nX\nX\nACE inhibitors\nX\nX\nX\nHMG CoA inhibitors\nX\nX\nX\nHeparin or antithrombin\nNO\nX\nX\nClopidogrel\nNO\nX\nX\nGPIIb/IIIa inhibitors\nNO\nX (if TIMI \u00053)\nNO\nFibrinolytics or PCIa\nNO\nNO\nX\nCardiology consult\nOutpatientb\nCCUc\nCCUc\nafor fibrinolytics, the ideal door to needle time is <30 min; for PCI, the ideal door to balloon time is <90 min;\nurgent CABG is also an option post catheterization\nbOutpatient cardiology for stress test\ncCCU consult for risk stratification, monitoring, PCI, and/or CABG\nCAUTIONS IN TREATMENT OF ACUTE MYOCAR\nDIAL INFARCTION\navoid negative inotropic agents\nsuch as b blockers and non dihydropyridine calcium\nchannel blockers if clinical heart failure. Avoid\nACUTE MANAGEMENT (CONT\u2019D)\nadministration of nitroglycerin, morphine, and diure\ntics to patients with right ventricular infarction as\nthese medications can cause venodilation and\ndecrease preload, leading to hypotension\nACUTE MANAGEMENT (CONT\u2019D)\nAcute Coronary Syndrome\n29", "text_length": 3817, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 43/464)", "type": "chunk", "chunk_index": 42, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.290666", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.291410", "status": "complete", "chunks_added": 2}